Johnson & Johnson Price to Book Ratio 2010-2024 | JNJ
Historical price to book ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current price to book ratio for Johnson & Johnson as of December 20, 2024 is 4.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Johnson & Johnson Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2024-12-20 |
144.47 |
|
4.96 |
| 2024-09-30 |
160.77 |
$29.14 |
5.52 |
| 2024-06-30 |
143.90 |
$29.72 |
4.84 |
| 2024-03-31 |
154.48 |
$29.09 |
5.31 |
| 2023-12-31 |
151.91 |
$28.57 |
5.32 |
| 2023-09-30 |
149.76 |
$29.59 |
5.06 |
| 2023-06-30 |
158.02 |
$29.41 |
5.37 |
| 2023-03-31 |
146.87 |
$27.27 |
5.38 |
| 2022-12-31 |
166.21 |
$29.39 |
5.66 |
| 2022-09-30 |
152.72 |
$28.51 |
5.36 |
| 2022-06-30 |
164.84 |
$29.04 |
5.68 |
| 2022-03-31 |
163.55 |
$28.41 |
5.76 |
| 2021-12-31 |
156.85 |
$28.16 |
5.57 |
| 2021-09-30 |
147.10 |
$26.69 |
5.51 |
| 2021-06-30 |
149.16 |
$26.44 |
5.64 |
| 2020-12-31 |
140.74 |
$24.04 |
5.85 |
| 2020-09-30 |
132.21 |
$24.49 |
5.40 |
| 2020-06-30 |
124.06 |
$23.92 |
5.19 |
| 2020-03-31 |
114.87 |
$23.28 |
4.93 |
| 2019-12-31 |
126.96 |
$22.59 |
5.62 |
| 2019-09-30 |
111.83 |
$22.13 |
5.05 |
| 2019-06-30 |
120.39 |
$23.01 |
5.23 |
| 2019-03-31 |
120.01 |
$22.20 |
5.41 |
| 2018-12-31 |
110.06 |
$22.44 |
4.90 |
| 2018-09-30 |
117.09 |
$24.09 |
4.86 |
| 2018-06-30 |
102.15 |
$23.45 |
4.36 |
| 2018-03-31 |
107.09 |
$23.58 |
4.54 |
| 2017-12-31 |
116.02 |
$22.43 |
5.17 |
| 2017-09-30 |
107.31 |
$27.55 |
3.89 |
| 2017-06-30 |
108.49 |
$26.78 |
4.05 |
| 2017-03-31 |
101.48 |
$26.10 |
3.89 |
| 2016-12-31 |
93.26 |
$26.02 |
3.58 |
| 2016-09-30 |
94.97 |
$26.73 |
3.55 |
| 2016-06-30 |
96.87 |
$26.47 |
3.66 |
| 2016-03-31 |
85.80 |
$26.40 |
3.25 |
| 2015-12-31 |
80.87 |
$25.82 |
3.13 |
| 2021-03-31 |
147.89 |
$25.01 |
5.91 |
| 2015-09-30 |
72.96 |
$25.86 |
2.82 |
| 2015-06-30 |
75.58 |
$25.69 |
2.94 |
| 2015-03-31 |
77.45 |
$24.45 |
3.17 |
| 2014-12-31 |
79.94 |
$25.06 |
3.19 |
| 2014-09-30 |
80.96 |
$27.31 |
2.96 |
| 2014-06-30 |
78.93 |
$27.65 |
2.85 |
| 2014-03-31 |
73.60 |
$27.08 |
2.72 |
| 2013-12-31 |
68.13 |
$26.25 |
2.60 |
| 2013-09-30 |
64.04 |
$24.75 |
2.59 |
| 2013-06-30 |
62.96 |
$24.75 |
2.54 |
| 2013-03-31 |
59.34 |
$23.85 |
2.49 |
| 2012-12-31 |
50.61 |
$23.33 |
2.17 |
| 2012-09-30 |
49.32 |
$23.08 |
2.14 |
| 2012-06-30 |
47.92 |
$21.97 |
2.18 |
| 2012-03-31 |
46.34 |
$22.35 |
2.07 |
| 2011-12-31 |
45.67 |
$20.95 |
2.18 |
| 2011-09-30 |
43.94 |
$22.52 |
1.95 |
| 2011-06-30 |
45.49 |
$22.67 |
2.01 |
| 2011-03-31 |
40.17 |
$21.86 |
1.84 |
| 2010-12-31 |
41.56 |
$20.66 |
2.01 |
| 2010-09-30 |
41.27 |
$20.85 |
1.98 |
| 2010-06-30 |
38.98 |
$19.19 |
2.03 |
| 2010-03-31 |
42.64 |
$19.19 |
2.22 |
| 2009-12-31 |
41.80 |
$18.37 |
2.28 |
| 2009-09-30 |
39.21 |
$18.27 |
2.15 |
| 2009-06-30 |
36.28 |
$16.79 |
2.16 |
| 2009-03-31 |
33.30 |
$15.87 |
2.10 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$345.687B |
$85.159B |
|
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
|
